BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 29621354)

  • 21. Implications of Nine Risk Prediction Models for Selecting Ever-Smokers for Computed Tomography Lung Cancer Screening.
    Katki HA; Kovalchik SA; Petito LC; Cheung LC; Jacobs E; Jemal A; Berg CD; Chaturvedi AK
    Ann Intern Med; 2018 Jul; 169(1):10-19. PubMed ID: 29800127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study.
    Tammemägi MC; Ruparel M; Tremblay A; Myers R; Mayo J; Yee J; Atkar-Khattra S; Yuan R; Cressman S; English J; Bedard E; MacEachern P; Burrowes P; Quaife SL; Marshall H; Yang I; Bowman R; Passmore L; McWilliams A; Brims F; Lim KP; Mo L; Melsom S; Saffar B; Teh M; Sheehan R; Kuok Y; Manser R; Irving L; Steinfort D; McCusker M; Pascoe D; Fogarty P; Stone E; Lam DCL; Ng MY; Vardhanabhuti V; Berg CD; Hung RJ; Janes SM; Fong K; Lam S
    Lancet Oncol; 2022 Jan; 23(1):138-148. PubMed ID: 34902336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early detection of lung cancer in a population at high risk due to occupation and smoking.
    Welch LS; Dement JM; Cranford K; Shorter J; Quinn PS; Madtes DK; Ringen K
    Occup Environ Med; 2019 Mar; 76(3):137-142. PubMed ID: 30415231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimating eligibility for lung cancer screening in an Australian cohort, including the effect of spirometry.
    Manners D; Hui J; Hunter M; James A; Knuiman MW; McWilliams A; Mulrennan S; Musk AW; Brims FJ
    Med J Aust; 2016 Jun; 204(11):406. PubMed ID: 27318396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Smoking pattern and risk of lung cancer among women participating in cancer screening programmes.
    Martín-Sánchez JC; González-Marrón A; Lidón-Moyano C; Matilla-Santander N; Fu M; Vidal C; Garcia M; Martinez-Sanchez JM
    J Public Health (Oxf); 2020 Feb; 42(1):90-97. PubMed ID: 30608591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of Lung Cancer Screening Eligibility Using Simplified Criteria.
    Triplette M; Donovan LM; Crothers K; Madtes DK; Au DH
    Ann Am Thorac Soc; 2019 Oct; 16(10):1280-1285. PubMed ID: 31298946
    [No Abstract]   [Full Text] [Related]  

  • 27. Lung cancer risk by years since quitting in 30+ pack year smokers.
    Pinsky PF; Zhu CS; Kramer BS
    J Med Screen; 2015 Sep; 22(3):151-7. PubMed ID: 25926339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts.
    Tammemägi MC; Church TR; Hocking WG; Silvestri GA; Kvale PA; Riley TL; Commins J; Berg CD
    PLoS Med; 2014 Dec; 11(12):e1001764. PubMed ID: 25460915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proportion of Non-Small-Cell Lung Cancer Patients that Would Have Been Eligible for Lung Cancer Screening.
    Wu GX; Goldstein L; Kim JY; Raz DJ
    Clin Lung Cancer; 2016 Sep; 17(5):e131-e139. PubMed ID: 26872765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Life-Gained-Based Versus Risk-Based Selection of Smokers for Lung Cancer Screening.
    Cheung LC; Berg CD; Castle PE; Katki HA; Chaturvedi AK
    Ann Intern Med; 2019 Nov; 171(9):623-632. PubMed ID: 31634914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing eligibility for lung cancer screening using parsimonious ensemble machine learning models: A development and validation study.
    Callender T; Imrie F; Cebere B; Pashayan N; Navani N; van der Schaar M; Janes SM
    PLoS Med; 2023 Oct; 20(10):e1004287. PubMed ID: 37788223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing Different Approaches to Leveraging Historical Smoking Exposure Data to Better Select Lung Cancer Screening Candidates: A Retrospective Validation Study.
    Kats DJ; Adie Y; Tlimat A; Greco PJ; Kaelber DC; Tarabichi Y
    Nicotine Tob Res; 2021 Aug; 23(8):1334-1340. PubMed ID: 32974635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of Selection Criteria for Low-Dose Lung Screening CT Among Asian Ethnic Groups in Taiwan: From Mass Screening to Specific Risk-Based Screening for Non-Smoker Lung Cancer.
    Wu FZ; Huang YL; Wu CC; Tang EK; Chen CS; Mar GY; Yen Y; Wu MT
    Clin Lung Cancer; 2016 Sep; 17(5):e45-e56. PubMed ID: 27133540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal-cell carcinoma risk estimates based on participants in the prostate, lung, colorectal, and ovarian cancer screening trial and national lung screening trial.
    Lotan Y; Karam JA; Shariat SF; Gupta A; Roupret M; Bensalah K; Margulis V
    Urol Oncol; 2016 Apr; 34(4):167.e9-16. PubMed ID: 26602092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resected Lung Cancer Patients Who Would and Would Not Have Met Screening Criteria.
    Farjah F; Wood DE; Zadworny ME; Rusch VW; Rizk NP
    Ann Thorac Surg; 2016 Jan; 101(1):274-9. PubMed ID: 26298169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LDCT lung cancer screening in populations at different risk for lung cancer.
    Teles GBDS; Macedo ACS; Chate RC; Valente VAT; Funari MBG; Szarf G
    BMJ Open Respir Res; 2020 Feb; 7(1):. PubMed ID: 33371010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the sensitivity of different criteria to select lung cancer patients for screening in a cohort of German patients.
    Walter J; Kauffmann-Guerrero D; Muley T; Reck M; Fuge J; Günther A; Majeed RW; Savai R; Koch I; Dinkel J; Schneider C; Senghas K; Kobinger S; Manapov F; Thomas M; Kahnert K; Winter H; Behr J; Tammemägi M; Tufman A
    Cancer Med; 2023 Apr; 12(7):8880-8896. PubMed ID: 36707972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preliminary Results of Lung Cancer Screening in a Socioeconomically Disadvantaged Population.
    Guichet PL; Liu BY; Desai B; Surani Z; Cen SY; Lee C
    AJR Am J Roentgenol; 2018 Mar; 210(3):489-496. PubMed ID: 29166147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluating efficacy of current lung cancer screening guidelines.
    Nemesure B; Plank A; Reagan L; Albano D; Reiter M; Bilfinger TV
    J Med Screen; 2017 Dec; 24(4):208-213. PubMed ID: 28201949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing the Generalizability of the National Lung Screening Trial: Comparison of Patients with Stage 1 Disease.
    Tanner NT; Dai L; Bade BC; Gebregziabher M; Silvestri GA
    Am J Respir Crit Care Med; 2017 Sep; 196(5):602-608. PubMed ID: 28722466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.